TopFunds

Viatris

NASDAQ: VTRS

Stock price

16.95 USD

(+24.91%) 5 years

PharmaceuticalsDrug Manufacturers - Specialty & Generic

Insider Transactions

5Y price score: 34
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: +24.91%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
30-jun.-26Award2,362--2,362SIMMONS DAVID Sdirectorlink
30-jun.-26Award2,756--2,756Groothuis Leo Fransdirectorlink
25-jun.-26Sale(50,076)16.2(809,784)316,212Campbell Paulofficer: See Remarkslink
23-mar.-26Sale(21,350)13.3(283,539)366,288Campbell Paulofficer: See Remarkslink
06-mar.-26Award88,984--88,984Le Goff Corinneofficer: Chief Commercial Officerlink
06-mar.-26Award86,017--86,017Mistras Theodoraofficer: Chief Financial Officerlink
06-mar.-26Award59,323--59,323Maletta Matthew Josephofficer: Chief Legal Officerlink
06-mar.-26Award15,890--15,890SEVERINO MICHAELdirectorlink
06-mar.-26Award60,435--60,435Enrietti Andrewofficer: See Remarkslink
06-mar.-26Award15,890--15,890PARRISH MARK Wdirectorlink

9.4

52-week range

18.3

16.95

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

9.5 %

Dividend Yield TTM

2.8 %

Market cap $

$ 19,739

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

(47.1)

Price / Book TTM

1.4

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

0.1

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

76.8 %

41.5 %

(54.1) %

Free cash flow per share growth

100.3 %

80.7 %

(50) %

Earnings per share growth

(2,464.1) %

(170.3) %

(276.5) %

Dividends

Previous dividend:0.12 per share, Paid, Ex-div date Aug 21, 2026

Analyst ratings

Price Target Low

20

Price Target High

22

Price Target Median

20

Buy

4

Hold

8

Sell

1

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
1.7
0.9
1.3
0.7
-
(1.1)
(1)
1.7
-
(0.5)
(3)
-
(0.1)
(0.1)
(0.1)
(0.1)
(0.1)
(0.1)
02FCF per share
3.3
3.2
3.3
4
2.7
0.9
2.1
2.1
1.9
1.7
1.7
(6.7)%
1.7
1.6
1.6
1.5
1.5
1.4
03Dividends per share
Help
Adjusted for splitsLearn more
-
-
-
-
-
-
0.3
0.5
0.5
0.5
0.5
9.8%
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
-
(31.4)%
28%
1,052.3%
(90.6)%
(16)%
(15.6)%
-
-
-
-
-
-
05Revenue
$ 9,429
$ 11,077
$ 11,908
$ 11,434
$ 11,501
$ 11,946
$ 17,886
$ 16,263
$ 15,427
$ 14,739
$ 14,300
4.3%
$ 14,908
$ 15,542
$ 16,203
$ 16,892
$ 17,610
$ 18,138
06ㅤ% Change
-
17.5%
7.5%
(4)%
0.6%
3.9%
49.7%
(9.1)%
(5.1)%
(4.5)%
(3)%
4.3%
4.3%
4.3%
4.3%
4.3%
4.3%
4.3%
07Net Income
847.6
480
696
352.5
16.8
(669.9)
(1,269)
2,079
54.7
(634.2)
(3,515)
-
(82)
(85.5)
(89.2)
(93)
(96.9)
(99.8)
08ㅤ% Margin
9%
4.3%
5.8%
3.1%
0.2%
(5.6)%
(7.1)%
12.8%
0.4%
(4.3)%
(24.6)%
(0.6)% A
(0.6)%
(0.6)%
(0.6)%
(0.6)%
(0.6)%
(0.6)%
09CFO
2,009
2,047
2,065
2,342
1,804
1,232
3,017
2,999
2,800
2,303
2,316
1.4%
2,560
2,669
2,782
2,900
3,024
3,114
10ㅤ% Of revenue
21.3%
18.5%
17.3%
20.5%
15.7%
10.3%
16.9%
18.4%
18.2%
15.6%
16.2%
17.2% A
17.2%
17.2%
17.2%
17.2%
17.2%
17.2%
11CAPEX
(362.9)
(390.4)
(275.9)
(252.1)
(406)
(681.2)
(509.4)
(489.4)
(474.5)
(326)
(378.8)
0.4%
(380.4)
(382.1)
(383.7)
(385.4)
(387)
(388.7)
12ㅤ% Change
-
7.6%
(29.3)%
(8.6)%
61.1%
67.8%
(25.2)%
(3.9)%
(3)%
(31.3)%
16.2%
0.4% A
0.4%
0.4%
0.4%
0.4%
0.4%
0.4%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
1,646
1,657
1,789
2,090
1,398
550.6
2,508
2,510
2,325
1,977
1,937
1.6%
2,179
2,287
2,398
2,515
2,637
2,726
14Total assets
22,268
34,726
35,806
32,735
31,256
61,553
54,843
50,022
47,686
41,501
37,193
5.3%
39,151
41,212
43,381
45,664
48,068
50,598
15ㅤ% Change
-
56%
3.1%
(8.6)%
(4.5)%
96.9%
(10.9)%
(8.8)%
(4.7)%
(13)%
(10.4)%
5.3%
5.3%
5.3%
5.3%
5.3%
5.3%
5.3%
16Total liabilities
12,502
23,609
22,499
20,568
19,372
38,599
34,350
28,950
27,218
22,865
22,482
6%
23,665
24,911
26,222
27,602
29,055
30,585
17ㅤ% Of assets
56.1%
68%
62.8%
62.8%
62%
62.7%
62.6%
57.9%
57.1%
55.1%
60.5%
60.5% A
60.5%
60.5%
60.5%
60.5%
60.5%
60.5%
18Shareholders Equity
9,766
11,118
13,308
12,167
11,884
22,954
20,493
21,072
20,467
18,636
14,711
4.2%
15,486
16,301
17,159
18,062
19,013
20,014
19Net Debt
6,070
14,474
14,369
13,430
12,449
25,317
22,657
18,268
17,379
13,571
13,353
8.2%
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
497,400
520,500
536,700
516,500
516,500
601,200
1,208,800
1,217,400
1,206,900
1,193,300
1,170,700
8.9%
1,275,321
1,389,292
1,513,448
1,648,700
1,796,038
1,956,544
21ㅤ% Change
-
4.6%
3.1%
(3.8)%
-
16.4%
101.1%
0.7%
(0.9)%
(1.1)%
(1.9)%
8.9%
8.9%
8.9%
8.9%
8.9%
8.9%
8.9%
22ROA
3.8%
1.4%
1.9%
1.1%
0.1%
(1.1)%
(2.3)%
4.2%
0.1%
(1.5)%
(9.5)%
-
(0.2)%
(0.2)%
(0.2)%
(0.2)%
(0.2)%
(0.2)%
23ROE
8.7%
4.3%
5.2%
2.9%
0.1%
(2.9)%
(6.2)%
9.9%
0.3%
(3.4)%
(23.9)%
-
(0.5)%
(0.5)%
(0.5)%
(0.5)%
(0.5)%
(0.5)%
24Interest coverage
4.3
1.5
2.7
1.7
1.4
(0.4)
(0.1)
2.7
1.3
-
(5.7)
-
-
-
-
-
-
-
25Dividend Yield
-
-
-
-
-
-
2.4%
4.3%
4.4%
3.9%
3.9%
-
-
-
-
-
-
-
26P/E Ratio
30
40.6
32.5
39.7
670
(16.9)
(12.9)
6.5
237.5
(23.5)
(4.1)
-
-
-
-
-
-
-
27Stock price range
39-76
34-54
30-45
26-48
17-32
13-23
12-19
8-15
9-12
10-14
7-13
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
26,894
19,857
22,652
14,152
11,256
11,267
16,355
13,491
12,999
14,857
14,575
(5.9)%
19,852
23,173
26,826
30,843
35,263
-
29FCF Yield
6.1%
8.3%
7.9%
14.8%
13.5%
4.9%
15.3%
18.6%
17.9%
13.3%
13.3%
8.1%
11%
9.9%
8.9%
8.2%
7.5%
-
30Average stock price
57.6
44.1
37.5
36.9
24.5
18.1
15.3
11.9
10.5
11.8
9.9
(16.2)%
15.6
16.7
17.7
18.7
19.6
-
31 CEO
SS
Scott Andrew Smith